Just saw the notification in my UHC portal — as of March 1, 2026, Zepbound (tirzepatide) has been added to the UnitedHealthcare commercial formulary for weight management! It's Tier 3 (preferred brand) with prior authorization required.

This is HUGE. UHC is the largest commercial insurer in the US, and they've been one of the biggest holdouts on GLP-1 coverage for weight loss. If I'm reading this right, the PA criteria are:

• BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity
• Documentation of 6+ months of lifestyle modification (diet/exercise)
• No requirement for prior medication failure (!!!!)

Can anyone else on UHC confirm? This could affect millions of people.

I'm a benefits manager for a mid-size company and we use UHC. Got the bulletin yesterday. A few important nuances:

This applies to UHC's STANDARD commercial formulary. However, employers can (and many do) customize their formulary. Self-insured employers can exclude weight management drugs even if they're on the standard formulary.

So whether this applies to YOU depends on whether your employer adopted the standard formulary or has a custom one. Call the number on your UHC member ID card and ask specifically: "Is tirzepatide (Zepbound) covered under my specific plan for weight management?"

For our company, I'm thrilled — we specifically requested GLP-1 coverage when we renewed last year and this is UHC delivering on that. Our employees with PA approval should see a $50 copay.

I just called UHC and confirmed — MY PLAN COVERS IT! I've been paying $549/month out of pocket with the Lilly savings card (no insurance coverage path). If this goes through, I'll be paying my $35 specialty copay + whatever the savings card covers.

I'm literally shaking. That's a savings of over $500/month. Over $6,000/year. This changes everything.

My doctor is submitting the PA tomorrow. Fingers crossed it goes through quickly.

Before everyone gets too excited — I also have UHC and I called. My plan does NOT cover it. My employer has a custom formulary that explicitly excludes "weight management medications."

I work for a large retail chain. When I asked HR, they said the exclusion was a cost decision. Adding GLP-1 coverage for their employee population would have increased premiums by an estimated 3-4%.

So yes, it's on the UHC standard formulary now, but your mileage will literally vary based on your employer. If your employer has excluded it, this change means nothing for you.

This could affect millions of people

It COULD, but many of those millions work for employers who will opt out. The real fight is getting employers to adopt the standard formulary for weight management drugs.

you're right to temper expectations. I should have been clearer that employer customization is a big factor.

For those whose employers DO exclude it, here's something to consider: talk to your HR department and benefits team. Many employers are reconsidering GLP-1 exclusions because:

1. The evidence for reduced downstream healthcare costs is now very strong
2. It's becoming an employee recruitment/retention issue — top talent is choosing employers with GLP-1 coverage
3. The cost increase is often offset by reductions in diabetes, cardiovascular, and orthopedic claims within 2-3 years

Some employers don't even realize the exclusion is in their plan. It was a default setting when they set up their benefits years ago and nobody questioned it.